To the best of our knowledge, this study is the first to investigate the expression of Tim-1 in thymoma patients with and without MG, and to examine whether the -1637A/G SNP in the promoter region of Tim-1 contributes to the susceptibility of thymoma with MG. The gene discussed is HAVCR1; the disease is myasthenia gravis.